Chylack, Leo T.
Harvard Medical School,
United States
2025 Rank: 55853
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 364 out of 81681 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 55853 | 60631 |
| Total Cites | 9437 | 10209 |
| H-index | 44 | 48 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 134 | 138 |
| Number of Single+First Authored Papers | 57 | 57 |
| Total Cites to Single+First Authored Papers | 3881 | 4023 |
| Number of Single+First+Last Authored Papers | 127 | 127 |
| Total Cites to Single+First+Last Authored Papers | 5441 | 5706 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7373 | 7687 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.33 |
| Self-Citation Percentage |
7.56%
|
|
Chylack, Leo T.
Harvard Medical School,
United States
2024 Rank: 52772
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 336 out of 77284 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 52772 | 57943 |
| Total Cites | 9022 | 9777 |
| H-index | 44 | 47 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 129 | 133 |
| Number of Single+First Authored Papers | 57 | 57 |
| Total Cites to Single+First Authored Papers | 3701 | 3842 |
| Number of Single+First+Last Authored Papers | 127 | 127 |
| Total Cites to Single+First+Last Authored Papers | 5216 | 5477 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7058 | 7371 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.33 |
| Self-Citation Percentage |
7.72%
|
|
Chylack, Leo T.
Harvard Medical School,
United States
2023 Rank: 50550
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 320 out of 72989 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 50550 | 54739 |
| Total Cites | 8692 | 9429 |
| H-index | 43 | 47 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 125 | 129 |
| Number of Single+First Authored Papers | 57 | 57 |
| Total Cites to Single+First Authored Papers | 3528 | 3668 |
| Number of Single+First+Last Authored Papers | 127 | 127 |
| Total Cites to Single+First+Last Authored Papers | 5002 | 5260 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6775 | 7077 |
| Ratio of Total Citations to Distinct Citing Papers | 1.28 | 1.33 |
| Self-Citation Percentage |
7.82%
|
|
Chylack, Leo T.
Harvard Medical School,
United States
2022 Rank: 47366
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 292 out of 69077 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 47366 | 51606 |
| Total Cites | 8223 | 8931 |
| H-index | 43 | 47 |
| Hm-index | 18 | 18 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 120 | 122 |
| Number of Single+First Authored Papers | 56 | 56 |
| Total Cites to Single+First Authored Papers | 3284 | 3412 |
| Number of Single+First+Last Authored Papers | 126 | 126 |
| Total Cites to Single+First+Last Authored Papers | 4695 | 4934 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6386 | 6682 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.34 |
| Self-Citation Percentage |
7.93%
|
|
Chylack, Leo T.
Harvard Medical School,
United States
2021 Rank: 46127
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 285 out of 65331 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46127 | 50481 |
| Total Cites | 7959 | 8658 |
| H-index | 42 | 45 |
| Hm-index | 17 | 18 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 118 | 120 |
| Number of Single+First Authored Papers | 56 | 56 |
| Total Cites to Single+First Authored Papers | 3174 | 3299 |
| Number of Single+First+Last Authored Papers | 125 | 125 |
| Total Cites to Single+First+Last Authored Papers | 4543 | 4776 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6171 | 6463 |
| Ratio of Total Citations to Distinct Citing Papers | 1.29 | 1.34 |
| Self-Citation Percentage |
8.07%
|
|
Chylack, Leo T.
Harvard Medical School,
United States
2020 Rank: 42636
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Ophthalmology & Optometry
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 277 out of 52338 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 42636 | 47172 |
| Total Cites | 7503 | 8193 |
| H-index | 42 | 45 |
| Hm-index | 17 | 18 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 115 | 117 |
| Number of Single+First Authored Papers | 56 | 56 |
| Total Cites to Single+First Authored Papers | 2940 | 3063 |
| Number of Single+First+Last Authored Papers | 124 | 124 |
| Total Cites to Single+First+Last Authored Papers | 4254 | 4484 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5781 | 6069 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.35 |
| Self-Citation Percentage |
8.42%
|
|